Frabex is a brand of tranexamic acid, an anti-fibrinolytic medicine that helps reduce bleeding by stabilising blood clots. It is made by Square Pharmaceuticals PLC. and comes as a 500 mg/5 ml injection.
There are 35 brands of Tranexamic Acid listed in Bangladesh. 14 of them have a lower unit price than Frabex. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.
What is Frabex 500 mg/5 ml Injection?
Frabex is an injection form of tranexamic acid, a medicine classed as an anti-fibrinolytic drug. It works by slowing down the natural breakdown of blood clots, which helps control bleeding in certain conditions. Doctors use it both in medical settings, such as bleeding linked to some blood and liver conditions, and around surgery. It is given by a healthcare professional, usually by slow injection into a vein or into a muscle. The strength is 500 mg/5 ml, supplied in a 5 ml ampoule in packs of six. Because it is given by injection, the doctor or pharmacist will decide the dose and course.
Uses of Frabex
Tranexamic acid injection is used to help prevent and treat bleeding in a range of situations. These include certain bleeding episodes in medical conditions such as leukaemia, cirrhosis and haemophilia, and accidental bleeding during clot-dissolving therapy or transfusion. It is also used around operations, including surgery on the lungs and heart, to help limit bleeding. Only a doctor can decide whether it is suitable for a particular person.
How to use Frabex
Frabex is given by injection, so it is administered by a doctor, nurse or other trained healthcare professional. It may be given slowly into a vein or into a muscle, depending on the doctor's decision. People receiving it should not try to use it themselves. The doctor chooses the dose, the route and how long it is continued, based on the reason it is being given and the person's condition. Ask the doctor or pharmacist about anything unclear.
Side effects of Frabex
Tranexamic acid is generally well tolerated, but some people may notice side effects. These can include a sense of tiredness, eye irritation, a blocked nose, itching, skin redness or a rash. Nausea, diarrhoea and stomach burning have been reported after oral use, and rare cases of low blood pressure on standing can occur. If there are signs of an allergic reaction, the medicine is stopped and suitable treatment started. Tell the doctor about any reaction.
Safety and precautions
Frabex should not be used by anyone with a known allergy to tranexamic acid or the product, or with a history of thromboembolic disease such as arterial or venous thrombosis, certain internal bleeding, or serious kidney failure. It is not to be given during known or suspected pregnancy, and it passes into breast milk in small amounts. It is used with caution in milder kidney problems. The doctor decides whether it is appropriate, so tell them about any medical conditions, medicines or pregnancy before it is given.
Frequently asked questions
What does the generic name tranexamic acid mean?
Tranexamic acid is the generic name of the active ingredient. It is a synthetic amino acid medicine classed as an anti-fibrinolytic drug, meaning it helps slow the breakdown of blood clots. Frabex is one brand of this medicine, made by Square Pharmaceuticals PLC.
What is Frabex used for and what kind of medicine is it?
Frabex is an anti-fibrinolytic injection of tranexamic acid, used to help prevent and treat bleeding in certain medical conditions and during some operations. It is given by a healthcare professional, and the doctor decides the dose and course for each person.
What side effects should I watch for, and when should I call the doctor?
Watch for tiredness, eye irritation, a blocked nose, itching, skin redness or rash, and after oral use nausea, diarrhoea or stomach burning. Signs of an allergic reaction or low blood pressure on standing should be reported. Call the doctor promptly if any reaction worries you.
What is the price of Frabex?
The listed price is ৳ 50.00. Ask the pharmacist about the price of the 5 ml ampoule and the pack, as it can vary.
In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.
In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.
In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.
In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.
In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.
In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.
Pharmacology
This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.
The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.
Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.
Dosage & Administration
Adults-
The usual dose: 500-1000 mg 3 times daily.
For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.
Interaction
Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.
Contraindications
Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.
Side Effects
Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
There are rare cases of postural hypotension.
In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.
Pregnancy & Lactation
Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.
Precautions & Warnings
Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
The administration of product requires particular care in cardiopathic and hepatopathic subjects.
Storage Conditions
Store in a dry place at 15-30°C, away from light and keep out of children's reach.
Alternative brands of Tranexamic Acid
Other brands with the same generic name, cheapest first.